PUBLISHER: 360iResearch | PRODUCT CODE: 1413139
PUBLISHER: 360iResearch | PRODUCT CODE: 1413139
[191 Pages Report] The Next-Generation IVD Market size was estimated at USD 80.22 billion in 2023 and expected to reach USD 83.58 billion in 2024, at a CAGR 7.16% to reach USD 130.23 billion by 2030.
Global Next-Generation IVD Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 80.22 billion |
Estimated Year [2024] | USD 83.58 billion |
Forecast Year [2030] | USD 130.23 billion |
CAGR (%) | 7.16% |
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Next-Generation IVD Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Next-Generation IVD Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Next-Generation IVD Market, highlighting leading vendors and their innovative profiles. These include ABL SA Group, Agilent Technologies Inc., Archer by Integrated DNA Technologies, Inc., Becton, Dickinson and Company, Biomerieux SA, BioVendor - Laboratorni medicina A.S., Cerba Research NV, Curetis N.V., Danaher Corporation, F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., Geneseeq Technology Inc., Genomic Labs Ltd., Illumina, Inc., Invivoscribe, Inc., NGenBio Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Pillar Biosciences Inc., QIAGEN GmbH, Sophia Genetics SA, Sysmex Europe SE, Tempus Labs, Inc., Thermo Fisher Scientific Inc., Trivitron Healthcare, and Vela Diagnostics Holding Pte Ltd..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Next-Generation IVD Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Next-Generation IVD Market?
3. What are the technology trends and regulatory frameworks in the Next-Generation IVD Market?
4. What is the market share of the leading vendors in the Next-Generation IVD Market?
5. Which modes and strategic moves are suitable for entering the Next-Generation IVD Market?